PTM1, The problem is FDA uses them to approve o
Post# of 151626
The problem is FDA uses them to approve or not. If we don't meet it we will be not selling any drugs

Helps to know before-hand what to expect to re-size the investment(s).
Looking forward to the publication of papers with more detailed analysis.
Also, it would help to have data on Mild-to-Moderate. This is a much larger market …
GLTU

